FDA Announces New Label Warnings on Opioid Medications

March 30, 2016

The U.S. Food and Drug Administration (FDA) has announced new requirements for safety labeling on immediate-release (IR) opioid pain medications such as oxycodone, hydrocodone and morphine. These changes are FDA’s latest action in its Action Plan to address the growing epidemic of opioid abuse in the United States, and is another “wake up call” to prescribers that the US Government is closely scrutinizing the prescription of opiates.

New York clients Click Here to read entire Legal Alert.

New Jersey clients Click Here to read entire Legal Alert.

Connecticut clients Click Here to read entire Legal Alert.

* * * * *

If you have any questions or need assistance with the information listed in this alert, please contact the GW attorney with whom you normally work.

About Garfunkel Wild, P.C.


Garfunkel Wild, P.C. was founded in 1980 with a single purpose in mind: to become a pre-eminent health care law firm attending to the unique business and legal needs of its clients. Since then, the firm has grown to over 70 attorneys devoted to addressing the complex legal, regulatory, business and financial needs of its diverse clients.

If you would like to receive Legal Alert mailings from Garfunkel Wild, P.C. electronically in the future, or if you would like to be removed from the mailing list, please contact us at (516) 393-2200 or eMail us at info@garfunkelwild.com.  You may also visit the Firm’s website.

 

THIS MATERIAL IS INTENDED AS INFORMATIONAL ONLY AND THE CONTENT SHOULD NOT BE CONSTRUED AS LEGAL ADVICE. READERS SHOULD NOT ACT UPON INFORMATION IN THIS MATERIAL WITHOUT FIRST SEEKING PROFESSIONAL ADVICE.